iQoncept/iStock via Getty Images As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitability, momentum, and estimate revisions immediately after reporting their quarterly performance. Of note, the Health Care Select S...
iQoncept/iStock via Getty Images As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitability, momentum, and estimate revisions immediately after reporting their quarterly performance. Of note, the Health Care Select Sector SPDR Fund ETF ( XLV ), which represents a sector holding a substantial 12.12% weight in the S&P 500, has emerged as a distinct laggard in the current market environment. Year-to-date, the XLV has declined 3.17%, starkly underperforming against the 9.17% gain seen in the broader S&P 500 benchmark index. To evaluate individual opportunities within this lagging sector, Seeking Alpha’s Quant system rates stocks on a scale from 1 to 5. Under this model, scores of 3.5 or above are classified as bullish, while scores of 2.5 or below indicate a bearish assessment. Post-earnings quant scorecard: Below is a summary of large-cap healthcare companies ($10B+) ranked by their current factor scores. Top-quant rated stocks: Centene Corporation ( CNC ), Quant Rating: 4.96 , Strong Buy. BrightSpring Health Services ( BTSG ), Quant Rating: 4.91 , Strong Buy. Jazz Pharmaceuticals ( JAZZ ), Quant Rating: 4.81 , Strong Buy. DaVita ( DVA ), Quant Rating: 4.79 , Strong Buy. Astellas Pharma ( ALPMY ), Quant Rating: 4.58 , Strong Buy. Bottom-quant rated stocks: CSL Limited ( CSLLY ), Quant Rating: 1.14 , Strong Sell. EssilorLuxottica ( ESLOY ), Quant Rating: 1.28 , Strong Sell. Shionogi & Co. ( SGIOY ), Quant Rating: 1.28 , Strong Sell. Insmed Incorporated ( INSM ), Quant Rating: 1.29 , Strong Sell. Daiichi Sankyo Company ( DSNKY ), Quant Rating: 1.34 , Strong Sell. More on healthcare stocks after earnings season AI Revolutionizing Biopharma: Faster, Better, Cheaper Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit Routine Vaccines Okay For Now: Investment Implications O...